Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function

Anna M Blom1, Bruno O Villoutreix, Björn Dahlbäck

  • 1Lund University Department of Clinical Chemistry, University Hospital Malmö, The Wallenberg Laboratory, S-205 02 Malmö, Sweden and INSERM U428, Université Paris V, Paris 75006, France. Anna.Blom@klkemi.mas.lu.se

Insights

C4b-binding protein (C4BP) mutants selectively lost cofactor activity for C4b and C3b cleavage. Despite normal binding, these mutants failed to induce conformational changes necessary for protease function, highlighting specific structural requirements for complement regulation.

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • C4b-binding protein (C4BP) is a key regulator of complement activation, inhibiting all pathways.
  • C4BP functions as a cofactor for serine protease factor I (FI) in degrading complement factors C4b and C3b.
  • C4BP structure involves alpha-chains (8 complement control protein domains) and a beta-chain (3 CCP domains).

Purpose of the Study:

  • To investigate the role of specific mutations in C4BP's alpha-chain CCP3 domain on its cofactor activity.
  • To determine if altered cofactor activity correlates with changes in C4b/C3b binding affinity or conformational changes.

Main Methods:

  • Site-directed mutagenesis to create C4BP mutants (K126Q/K128Q and F144S/F149S) in the alpha-chain CCP3 domain.
  • Surface plasmon resonance (SPR) to measure binding affinity of mutants to C4b/C3b.
  • Assays to assess cofactor activity in C4b and C3b cleavage and inhibitory effects on C3-convertase.

Main Results:

  • Two C4BP mutants (K126Q/K128Q and F144S/F149S) selectively lost cofactor activity for C4b and C3b cleavage.
  • These mutants exhibited normal binding affinity for C4b/C3b and similar inhibitory effects on C3-convertase as wild-type C4BP.
  • The data suggest that C4b and C3b do not undergo the same conformational changes upon binding to the mutants as with wild-type C4BP.

Conclusions:

  • Specific residues within C4BP's alpha-chain CCP3 are critical for its cofactor function, independent of substrate binding affinity.
  • The loss of cofactor activity in mutants is attributed to impaired conformational changes in C4b/C3b upon binding.
  • These findings elucidate the mechanism of C4BP-mediated complement regulation and identify key structural determinants for cofactor activity.

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Mutations02:27

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cofactors and Coenzymes01:24

Cofactors and Coenzymes

Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes01:27

Cofactors and Coenzymes

Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.